Bisphosphonates and bone metastases

This publication has 9 references indexed in Scilit:

• Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma.
  BMJ, 1988
• Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP.
  Journal of Clinical Oncology, 1988
• Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy
  BMJ, 1988
• REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT
  The Lancet, 1987
• Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer.
  BMJ, 1987
• ABSORPTION OF ORAL DIPHOSPHONATE IN NORMAL SUBJECTS
  Clinical Endocrinology, 1986
• Structure-activity relationships of various bisphosphonates
  Calcified Tissue International, 1983
• LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASES
  The Lancet, 1983
• The effects of diphosphonates on the exchangeable and non-exchangeable calcium and phosphate of hydroxyapatite
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1972